Fulvestrant—Another Option for Breast Cancer Treatment
En Español (Spanish Version)


Fulvestrant is approved for postmenopausal women with a certain type of breast cancer, called hormone receptor-positive metastatic breast cancer. If the cancer is not responsive to tamoxifen, then fulvestrant is an option. Fulvestrant is given once a month as a shot in the gluteal muscle.

Estrogen's Role
Like the medication tamoxifen, fulvestrant is classified as anti-estrogen therapy. These drugs are designed to treat the forms of breast cancer that are sensitive to the hormone estrogen. In such cases, there are estrogen receptors on the outside of the breast cancer cells. These receptors take in estrogen, which stimulates their growth.

Each anti-estrogen drug works by a slightly different mechanism, making it possible for these drugs to be used in sequence. This means that doctors have more weapons to fight breast cancer, and they may be able to control the cancer for a longer period of time. Tamoxifen blocks estrogen from reaching the estrogen receptor in breast cancer cells. Fulvestrant blocks and destroys estrogen receptors in breast cancer cells.

Side Effects
The most common side effects include:

  • Nausea
  • Vomiting
  • Constipation
  • Diarrhea
  • Abdominal pain
  • Headache
  • Back pain
  • Weakness
  • Hot flashes
  • Sore throat
Who Should Not Take Fulvestrant?
You will not be able to take fulvestrant if you:

  • Are pregnant or breastfeeding
  • Are allergic to any of the ingredients
Tell your doctor about any medications, including over-the-counter medications and herbs and supplements, before starting fulvestrant.




RESOURCES:
National Cancer Institute

US Food and Drug Administration

CANADIAN RESOURCES:
Canadian Cancer Society


References:
Faslodex (fulvestrant) injection. DailyMed website. Available at: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=83d7a440-e904-4e36-afb5-cb02b1c919f7. Updated November 2012. Accessed October 6, 2014.

Tamoxifen. American Cancer Society website. Available at: http://www.cancer.org/treatment/treatmentsandsideeffects/guidetocancerdrugs/fulvestrant. Updated December 27, 2012. Accessed October 6, 2014.

Fulvestrant. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated March 12, 2014. Accessed October 6, 2014.

Tamoxifen. American Cancer Society website. Available at: http://www.cancer.org/treatment/treatmentsandsideeffects/guidetocancerdrugs/tamoxifen. Updated February 11, 2010. Accessed October 6, 2014.

Last Reviewed September 2014



Health Information Library content is provided by EBSCO Publishing, fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.

 

This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.

 

To send comments or feedback to EBSCO's Editorial Team regarding the content please e-mail healthlibrarysupport@ebscohost.com.